Home / PDA Letters (Cards)

PDA Letters (Cards)

PDA Responds to the Novel Coronavirus Situation

Richard Johnson, PDA President

Tools to Address Human Error Reduction

Tony Yang, Communications Board Chair, Pacific Northwest Chapter

40 Years of Visual Inspection: Where Do We Go from Here?

Romain Veillon, GSK Vaccines, and John Shabushnig, PhD, Insight Pharma Consulting, LLC

Inaugural BioManufacturing Conference Tackles Five Key Issues: Part II

Michael De Felippis, PhD, Eli Lilly, and Cristiana Campa, PhD, GSK 

Data Integrity: From the Basics to Big Data

David Hubmayr, CSL Behring

Innovations in Aseptic Processing

Rebecca Stauffer, PDA

Annex 1 to VPHP: The ABCs of Aseptic Processing

Shelly Henderson

Inaugural BioManufacturing Conference Tackles Five Key Issues: Part I

Michael DeFelippis, PhD, Eli Lilly, and Cristiana Campa, PhD, GSK

Board of Directors Nominations Needed

Rebecca Stauffer, PDA

New Decade, New Focus for PDA Letter

Rebecca Stauffer, PDA

Female Biotech Leaders Discuss Their Career Journeys, Offer Advice

Katja Yount, PDA

5.0 Ways Quality 4.0 Will Improve Manufacturing

Snehal Srikrishna, Veeva Systems

Could A.I. Optimize Visual Inspection?

Andreas Gross, Syntegon

4 Questions and 4 Answers About Innovation in Pharma Manufacturing

Rebecca Stauffer, PDA

A Glimpse at FDA’s Micro Regulations

Rebecca Stauffer, PDA

EPA Hearing on EtO Draws Debate

Rebecca Stauffer, PDA

The Product Quality Leader Team Part I: Building the PQL Role

Stephan Krause, PhD; Mariam Khan; Callum Chapman; Rob Gaglione; Andy Spasoff; Anthony Mire-Sluis, AstraZeneca

Panel Inspires Next Generation of Female Biotech Leaders

Tony Yang, Communications Board Chair, Pacific Northwest Chapter

5 Challenges of Closed System Transfer Devices

Cathy Zhao, PhD, and Allison Radwick, PhD, West Pharmaceutical Sciences

PDA Enters 2020 on Strong Note

Jette Christensen, Novo Nordisk